Titolo |
Pubblicato in |
Anno |
Update on the diagnosis and treatment of pericardial diseases: a position paper of the Italian Society of Cardiology in collaboration with the study group on cardiomyopathies and pericardial diseases |
JOURNAL OF CARDIOVASCULAR MEDICINE |
2025 |
Critical approach to the 2023 European Society of Cardiology guidelines on cardiomyopathies: a document by the Working Group on Myocardial and Pericardial Diseases of the Italian Society of Cardiology |
JOURNAL OF CARDIOVASCULAR MEDICINE |
2025 |
Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes |
INTERNATIONAL JOURNAL OF CARDIOLOGY |
2024 |
Position statement of the Italian Society of Cardiovascular Prevention (SIPREC) and Italian Heart Failure Association (ITAHFA) on cardiac rehabilitation and protection programs as a cornerstone of secondary prevention after myocardial infarction or revascularization |
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION |
2024 |
Transcatheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: A Multicenter Propensity Score-Based Analysis |
JACC. ADVANCES |
2024 |
Re-analysis of Next-generation Sequencing Data in Patients with Hypertrophic Cardiomyopathy: Contribution of Spliceogenic MYBPC3 Variants in an Italian Cohort |
ANNALS OF LABORATORY MEDICINE |
2024 |
Impact of the Noninvasive Diagnostic Algorithm on Clinical Presentation and Prognosis in Cardiac Amyloidosis |
JACC. ADVANCES |
2024 |
Arrhythmic risk stratification in patients with left ventricular ring-like scar |
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY |
2024 |
A Novel Nonsense Pathogenic TTN Variant Identified in a Patient with Severe Dilated Cardiomyopathy |
CURRENT ISSUES IN MOLECULAR BIOLOGY |
2023 |
Natriuretic Peptides: It Is Time for Guided Therapeutic Strategies Based on Their Molecular Mechanisms |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2023 |
Risk stratification in transthyretin-related cardiac amyloidosis |
FRONTIERS IN CARDIOVASCULAR MEDICINE |
2023 |
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study |
EUROPEAN JOURNAL OF HEART FAILURE |
2023 |
Diagnostic Delay in Arrhythmogenic Cardiomyopathy |
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY |
2023 |
Old and new therapeutic solutions in the treatment of hypertrophic cardiomyopathy |
EUROPEAN HEART JOURNAL SUPPLEMENTS |
2023 |
Long QTc in hypertrophic cardiomyopathy: A consequence of structural myocardial damage or a distinct genetic disease? |
FRONTIERS IN CARDIOVASCULAR MEDICINE |
2023 |
From the phenotype to precision medicine: an update on the cardiomyopathies diagnostic workflow |
JOURNAL OF CARDIOVASCULAR MEDICINE |
2023 |
Substrates of Scar-Related Ventricular Arrhythmia in Patients With Hypertrophic Cardiomyopathy: A Cardiac Magnetic Resonance Study |
JACC. CARDIOVASCULAR IMAGING |
2023 |
The role of genetic testing in suspected fulminant myocarditis: A case report |
MOLECULAR GENETICS AND METABOLISM REPORTS |
2023 |
Clinical Course of Hypertrophic Cardiomyopathy Patients Implanted with a Transvenous or a Subcutaneous Defibrillator |
EUROPACE |
2023 |
Electrocardiographic heterogeneity of patients with variant transthyretin amyloid cardiomyopathy: Genotype-phenotype correlations |
INTERNATIONAL JOURNAL OF CARDIOLOGY |
2023 |